Screener
Opus Genetics IRD Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Opus Genetics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034084
FAQ
- What is Opus Genetics's accrued expenses?
- Opus Genetics (IRD) reported accrued expenses of $795K in Q1 2026.
- How has Opus Genetics's accrued expenses changed year-over-year?
- Opus Genetics's accrued expenses increased by 54.4% year-over-year, from $515K to $795K.
- What is the long-term trend for Opus Genetics's accrued expenses?
- Over 5 years (2020 to 2025), Opus Genetics's accrued expenses has grown at a 0.2% compound annual growth rate (CAGR), from $1.97M to $1.99M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Opus Genetics's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude